Inovyn announces investment in a new state-of-the-art membrane cellroom
Chemical

Inovyn announces investment in a new state-of-the-art membrane cellroom

Chlorine produced in the new cellroom will mainly be supplied to INEOS Oxide at its Cologne Site, whilst the caustic soda will be sold in the European market

  • By ICN Bureau | November 08, 2017

Leading vinyls producer, Inovyn is making major investment in a new state-of-the-art membrane cellroom for the production of chlorine and caustic soda that will be located at Cologne in Germany. Initial design and feasibility studies are currently underway and the company hopes to complete the project by 2021.

The chlorine produced in the new cellroom will mainly be supplied to INEOS Oxide to support its strategy to increase propylene oxide production at its Cologne Site, whilst the caustic soda will be sold in the European market, underpinning security of supply to Inovyn’s customers.

According to Chris Tane, CEO of Inovyn, “Our planned project at Cologne is another major investment by Inovyn that will underpin the sustainability and competitiveness of our business in the long term. Specifically, this investment is a clear sign of Inovyns ongoing commitment to its European caustic soda customers.”

This Project forms part of Inovyn’s substantial chlor-alkali investment programme, which has so far included a well advanced membrane cellroom conversion at Stenungsund (Sweden), as well as the recently completed expansion of its membrane chlorine cellroom at Antwerp/Lillo (Belgium) and a major investment in a large scale potassium hydroxide (KOH) production facility at the same site.

Register Now to Attend Gujarat Chem & Petchem Conference 2025 on May 8-9th 2025, at Hyatt Place, Bharuch

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization